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540 Abstracts August 2014Conclusions: Sn-renals angled more inferiorly than F-renals due
to patient selection and stent conﬁguration. Upward respiratory-
induced deformation of the celiac artery exceeded that of stented re-
nals, likely related to lack of intravascular stent placement. Sn-renals
exhibited signiﬁcant curvature change during respiration, a ﬁnding
that may warrant increased surveillance based on known mechanisms
of stent-induced renal artery thrombosis. Further investigation is war-
ranted to better optimize anatomic, patient, and branch vessel stent
type selection between fenestrated and snorkel strategies and their rela-
tionship to long-term patency.
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Zenith p-Branch Fenestrated Endovascular Graft: How Close “Off-
the-Shelf ” Repair for Asian Patients with Juxtarenal Aortic
Aneurysms?
Jiale Ou, Stephen WK. Cheng. Surgery, The University of Hong Kong,
Hong Kong, China
Objective: The Zenith pivot branch fenestrated endovascular graft
(p-branch) is a new “off-the-shelf” device to treat patients with juxtarenal
aortic aneurysms (JRA). Two options are currently available based on
Caucasian anatomy, differing in the longitudinal distance between the supe-
rior mesenteric artery (SMA) and the renal fenestrations. This study inves-
tigates the anatomical suitability of the P-branch fenestrated grafts in a
cohort of Asian patients with JRA.
Methods: Computed tomography images of 51 consecutive pa-
tients (43 men; mean age, 76.8 years) with JRA from our hospital
database, were analyzed using the TeraRecon Aquarius workstation
(San Mateo, Calif). The renal clock positions differed with the variation
in graft diameters (range, 26-36 mm). Using the native paravisceral
aortic diameter as reference, the artery positions were converted to
circumferential locations and then mapped together with the diameters
of corresponding arteries. Their geometric locations were then applied
to the P-branch option A and B (single SMA and two renal fenestra-
tions, and a scallop). The suitability of these stent graft designs to
the aneurysm was evaluated.Fig. The three black circles represent the pivot fenestrations of the superior
mesenteric artery and the two renal arteries, and the rectangle is the scallop.
The ﬁlled circles stand for the celiac trunk (green) and left (red) and right
(blue) renal arteries. The size of the circles represents the actual diameter of
the corresponding artery. A, Perfectly suitable: all the visceral oriﬁces
located inside the fenestrations or scallop. B,Marginally suitable: part of the
renal oriﬁce (left) located outside the fenestration. C and D, Candidates for
the 26-mm and 30-mm graft, respectively.Results: A total of 31 JRA patients (60.8%) were regarded as suit-
able candidates for one or both p-branch endografts (20 with option
A, 22 with option B, and 11 with both options). In 35 patients
(68.6%), both renal arteries could be aligned with the fenestrations.
Among them, 16 patients (31.4%) were perfectly matched, while
19 patients (37.2%) were only marginally suitable (Fig). The major
reason for the exclusion was the misalignment of the renal pivots,
mainly due to the longitudinal position of renal arteries rather than the
circumferential position, particularly the longer distance of the right
renal arteries from the SMA. If the right renal fenestration of option B
was adjusted to 20-mm caudal to the SMA fenestration (level with the
left fenestration), the match could reach 78.4% (40 of 51). Other
reasons were unsuitable scallops for the celiac axis in four patients
(7.84%) and insufﬁcient length of the abdominal aorta to accommodate
the graft in another four patients.
Conclusions: The present designs of the p-branch fenestrated graft
are suitable for a good proportion of JRA patients in Asia. Further reﬁne-
ment of design may be necessary to accommodate the anatomical variations,
especially a lower right renal artery.
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Initial Experience with Endovascular Treatment of Thoracoabdominal
Aortic Aneurysm Using Physician-Modiﬁed Endografts: B-TEVAR
IDE Study
Matthew P. Sweet, MD, Benjamin W. Starnes, MD, Billi Tatum, RN,
CRCC. University of Washington, Seattle, Wash
Objective: This study reports an initial single-center experience of pa-
tients with physician-modiﬁed thoracic endografts for endovascular treat-
ment of thoracoabdominal aortic aneurysm (TAAA).
Methods: Patients were included if treated urgently for symptomatic
TAAA (n ¼ 2) as well as those treated in a Phase 1 clinical trial (n ¼ 11), an
Food and Drug Administration-approved physician sponsored investiga-
tional device exemption (B-TEVAR IDE). Patients were included if they
had a TAAA and were deemed to be at high risk with open repair and
met study inclusion criteria.
Results: Thirteen patients (nine men and four women) with TAAA
were treated with branched-fenestrated endovascular stent grafts. Demo-
graphic and operative details are reported in Tables I and II. Nine pa-
tients (69%) had successful treatment: return to preoperative functional state
and complete aneurysm exclusion at mean 8 months (range, 1-28 months)
of follow-up. Two patients (15%) died. One patient died on the 22nd
postoperative day of complications of spinal cord ischemia. Another patient
died 4 months after repair of bacterial endocarditis from a foot infection.
One other patient had successful aneurysm exclusion but suffered perma-
nent spinal cord injury. One patient is clinically well despite presence of a
type III endoleak.
Conclusions: Totally endovascular treatment of TAAA using a
physician-modiﬁed thoracic endograft is feasible. Although it can be
done using minimally invasive means, it remains a high-risk procedure.
B-TEVAR is highly adaptable to complex anatomy and can be done
with current commercially available devices. This treatment may pro-
vide a safe and effective means of treatment of TAAA among patients
at high risk of open repair. This early experience has provided insights
into the safe conduct of these procedures, including staged repair, and
methods of case planning.Table I. Demographics
Variables Mean (range) or No. (%) (n ¼ 13)
Age, years 72 (63-88)
TAAA extent
1 2 (15)
2 3 (23)
3 4 (31)
4 3 (23)
5 1 (8)
Diameter, cm 6.8 (5.5-9.1)
Symptomatic 2 (15)
Prior aortic operation 5 (38)
TAAA, Thoracoabdominal aortic aneurysm.
